B Cell Subsets as Sever Severity-Associated Signatures in COVID-19 Patients
SARS-CoV-2 infection represents a global health problem that has affected millions of people. The fine host immune response and its association with the disease course have not yet been fully elucidated. The severity of COVID-19 is accompanied by changes in the B cell subpopulations. These lymphocytes could serve as potential biomarkers and even active participants in the adaptive antiviral response mounted against SARS-CoV-2.
